文献速递其他结缔组织病

抗SAE抗体阳性皮肌炎患者的纵向研究:中国多中心队列研究

Longitudinal study of patients with anti-SAE antibody-positive dermatomyositis: a multicenter cohort study in China.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究回顾性纳入中国四家三级转诊中心2005年3月至2022年12月的抗SAE抗体阳性皮肌炎患者,进行长期生存分析、器官损害与皮肤皮疹评估、纵向CT模式分析及无监督聚类分析。全因死亡率为10.5%(4/38),其中3例死于恶性肿瘤;35.3%患者处于无药缓解,70.6%的存活患者存在器官损害,以皮肤损害为主(47.1%)。

要点

  • 抗SAE抗体阳性皮肌炎患者全因死亡率为10.5%(4/38),恶性肿瘤是主要死因。
  • 35.3%患者达无药缓解,70.6%存活患者存在器官损害,皮肤损害占47.1%。
  • 合并间质性肺病的患者重复CT显示6个月时明显改善或12个月后稳定。

核心结论

  • 抗SAE抗体阳性皮肌炎以较低死亡率为特征,恶性肿瘤是主要死因。
  • 存活患者存在显著皮肤损害,而间质性肺病趋于稳定。
  • 无监督聚类分析识别的聚类可辅助医生识别死亡风险较高的患者。

研究设计与样本

  • 回顾性纳入中国四家三级转诊中心2005年3月至2022年12月的抗SAE抗体阳性皮肌炎患者。
  • 采用肌炎损害指数和皮肤疾病面积与严重程度指数评估器官损害程度和皮疹范围。
  • 进行长期生存分析、纵向CT模式分析,并采用无监督聚类分析表征表型。

主要发现

  • 全因死亡发生于10.5%(4/38)的患者,其中3例死于恶性肿瘤,死亡时间分别为13、18和36个月。
  • 35.3%的患者处于无药缓解。
  • 皮肤疾病面积与严重程度指数评估显示皮疹随时间显著改善。
  • 70.6%的存活患者经肌炎损害指数评估存在不同系统损害,主要为皮肤损害,占47.1%。
  • 9例抗SAE抗体阳性皮肌炎相关间质性肺病患者重复CT显示6个月时放射学明显改善或12个月后稳定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the longitudinal study and long-term prognosis of a multicentre large inception cohort of patients with anti-SAE positive DM. METHODS: We retrospectively recruited patients with anti-SAE+DM in four tertiary referral centres from China between March 2005 and December 2022. Long-term survival analysis was performed on the enrolled patients. The Myositis Damage Index and Cutaneous Disease Area and Severity Index were used to evaluate the degree of different organ damage and the extent of skin rashes. Longitudinal CT patterns were analysed. Phenotypes were characterized using unsupervised cluster analysis. RESULTS: All-cause death occurred in 10.5% (4/38) of all patients, in which three patients succumbed to malignancies at 13, 18 and 36 months. Most patients had favourable long-term outcomes, 35.3% of them were in drug-free remission. Skin rashes showed significant improvement evaluated by Cutaneous Disease Area and Severity Index with time. However, damage to different systems was observed in 70.6% of the surviving patients using the Myositis Damage Index, which mainly consisted of skin damage, accounting for 47.1%. Nine patients with anti-SAE+DM-associated interstitial lung disease underwent repeat CT showed marked radiological improvement at 6 months or being stable after 12 months. In further, different characteristics and outcomes were also showed in three clusters identified by unsupervised analysis. CONCLUSIONS: Anti-SAE+DM is characterized with a lower mortality rate and the development of malignancies being the primary cause of death. Patients who survived showed notable cutaneous damage, while the interstitial lung disease tends to stabilize. Clusters identified with unsupervised analysis could assist physicians in identifying a higher risk of mortality.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zhang Y, Liu L, Duan X, et al. Longitudinal study of patients with anti-SAE antibody-positive dermatomyositis: a multicenter cohort study in China. Rheumatology (Oxford). 2025. PMID: 38648758. doi:10.1093/rheumatology/keae232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。